Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pediatric Brain Tumor × Control Groups × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 7 Motor Activity 5 Pain, Postoperative 4 Stomach Neoplasms 3 Vomiting 2 Nausea 2 Lung Neoplasms 2 Liver Diseases 2 Fatigue 2 Colorectal Neoplasms 2 Chronic Pain 2 Cancer Pain 2 Agnosia 2 Uterine Cervical Neoplasms 1 Ulcer 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Peripheral Nervous System Diseases 1 Pediatric Brain Tumor 1 Pathologic Processes 1 Papillomavirus Infections 1 Pain 1 Osteolysis 1 Neuroendocrine Tumors 1 Nasopharyngeal Carcinoma 1

Interventions

dapagliflozin 1 Topotecan 1 Tomography, X-Ray Computed 1 Magnetoencephalography 1 Magnetic Resonance Imaging 1 High-Intensity Interval Training 1 Cyclophosphamide 1 Control Groups 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05740839 2026-02-24

HYPE

Dana-Farber Cancer Institute

Phase NA Recruiting

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡